Revolutionising Cancer Treatment: Personalised Medicine

0 Views

07/13/23

There was little hope when 24-year-old Donavan Koh was diagnosed with Stage 4 natural killer (NK) cell lymphoma, a rare, terminal cancer. But a clinical study and an AI-driven digital medicine platform called Quadratic Phenotypic Optimisation Platform (QPOP) helped him fend off the disease for 16 months.

READ MORE: https://cna.asia/3U4zbtI

Using QPOP, the team behind it can "come up with the best cocktails of these anti-cancer drugs, which are … bespoke for our particular patients,” said Anand Jeyasekharan, an assistant professor at the National University of Singapore (NUS) Centre for Cancer Research (N2CR).

The individualised treatment offered through QPOP is a departure from cancer treatments where doctors follow standard protocols.

IN THIS VIDEO:
00:00 What is natural killer (NK) cell lymphoma?
01:50 Using artificial intelligence to better cancer treatment
02:10 How digital medicine platform Quadratic Phenotypic Optimisation Platform (QPOP) works
03:23 How personalised treatment helped Donavan fend off cancer for more than a year
06:15 Words from a cancer warrior

Produced in partnership with the NUS Yong Loo Lin School of Medicine.

For more, SUBSCRIBE to CNA INSIDER!
https://cna.asia/insideryoutubesub

Follow CNA INSIDER on:
Instagram: https://www.instagram.com/cnainsider/
Facebook: https://www.facebook.com/cnainsider/
Website: https://cna.asia/cnainsider